Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurogene (NGNE) Free Cash Flow: 2012-2024

Historic Free Cash Flow for Neurogene (NGNE) over the last 13 years, with Dec 2024 value amounting to -$71.4 million.

  • Neurogene's Free Cash Flow fell 24.73% to -$19.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$78.4 million, marking a year-over-year decrease of 10.64%. This contributed to the annual value of -$71.4 million for FY2024, which is 38.01% down from last year.
  • Latest data reveals that Neurogene reported Free Cash Flow of -$71.4 million as of FY2024, which was down 38.01% from -$51.7 million recorded in FY2023.
  • In the past 5 years, Neurogene's Free Cash Flow ranged from a high of -$26.8 million in FY2020 and a low of -$71.4 million during FY2024.
  • Over the past 3 years, Neurogene's median Free Cash Flow value was -$55.1 million (recorded in 2022), while the average stood at -$59.4 million.
  • As far as peak fluctuations go, Neurogene's Free Cash Flow crashed by 89.67% in 2021, and later rose by 6.01% in 2023.
  • Over the past 5 years, Neurogene's Free Cash Flow (Yearly) stood at -$26.8 million in 2020, then plummeted by 89.67% to -$50.8 million in 2021, then decreased by 8.33% to -$55.1 million in 2022, then increased by 6.01% to -$51.7 million in 2023, then crashed by 38.01% to -$71.4 million in 2024.